PNPLA2 and fatty liver disease: The lncRNA SRA (steroid receptor RNA activator) was shown to promote hepatic steatosis via repression of adipose triglyceride lipase (Atgl) by inhibiting transcriptional activity of forkhead box protein O1 (FoxO1).